Ninety One North America’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.71M Hold
7,390
0.17% 81
2026
Q1
$3.63M Buy
7,390
+48
+0.7% +$26.1K 0.16% 75
2025
Q4
$4.25M Buy
+7,342
New +$4.15M 0.17% 70
2025
Q2
Sell
-2,205
Closed -$1.1M 69
2025
Q1
$1.1M Sell
2,205
-352
-14% -$191K 0.07% 58
2024
Q4
$1.33M Sell
2,557
-335
-12% -$184K 0.08% 57
2024
Q3
$1.79M Buy
+2,892
New +$1.71M 0.12% 49
2023
Q3
Sell
-12,356
Closed -$6.45M 87
2023
Q2
$6.45M Sell
12,356
-492
-4% -$265K 0.27% 45
2023
Q1
$7.41M Sell
12,848
-493
-4% -$278K 0.34% 34
2022
Q4
$7.35M Buy
13,341
+94
+0.7% +$49.8K 0.36% 32
2022
Q3
$6.72M Hold
13,247
0.32% 33
2022
Q2
$7.2M Buy
13,247
+6,122
+86% +$3.37M 0.32% 35
2022
Q1
$4.21M Buy
7,125
+305
+4% +$175K 0.15% 77
2021
Q4
$4.55M Sell
6,820
-271
-4% -$169K 0.16% 80
2021
Q3
$4.05M Buy
7,091
+135
+2% +$74.1K 0.19% 74
2021
Q2
$3.51M Sell
6,956
-127
-2% -$59.9K 0.16% 83
2021
Q1
$3.23M Sell
7,083
-17,355
-71% -$8.28M 0.19% 84
2020
Q4
$11.4M Sell
24,438
-756
-3% -$354K 0.7% 38
2020
Q3
$11.1M Buy
25,194
+1,754
+7% +$725K 1.22% 25
2020
Q2
$8.49M Sell
23,440
-36,764
-61% -$12.3M 0.88% 23
2020
Q1
$17.1M Sell
60,204
-32,751
-35% -$10.3M 1.42% 30
2019
Q4
$30.2M Sell
92,955
-10,412
-10% -$3.16M 2.46% 8
2019
Q3
$30.1M Buy
103,367
+5,215
+5% +$1.49M 2.72% 5
2019
Q2
$28.8M Buy
98,152
+9,961
+11% +$2.74M 2.54% 9
2019
Q1
$24.1M Sell
88,191
-23,929
-21% -$5.96M 2.28% 11
2018
Q4
$25.1M Sell
112,120
-1,090
-1% -$256K 2.67% 8
2018
Q3
$27.6M Sell
113,210
-19,954
-15% -$4.59M 2.37% 8
2018
Q2
$27.6M Sell
133,164
-705
-0.5% -$150K 1.98% 15
2018
Q1
$27.6M Buy
133,869
+62,019
+86% +$13M 2.1% 13
2017
Q4
$13.6M Sell
71,850
-3,175
-4% -$608K 2.17% 15
2017
Q3
$14.2M Buy
75,025
+5,626
+8% +$1.02M 2.4% 8
2017
Q2
$12.1M Buy
69,399
+58,227
+521% +$9.78M 2.22% 16
2017
Q1
$1.72M Sell
11,172
-204
-2% -$31.2K 0.32% 50
2016
Q4
$1.6M Sell
11,376
-131
-1% -$19.3K 0.24% 75
2016
Q3
$1.83M Hold
11,507
0.25% 81
2016
Q2
$1.7M Buy
11,507
+1,600
+16% +$236K 0.25% 80
2016
Q1
$1.4M Buy
9,907
+880
+10% +$118K 0.23% 80
2015
Q4
$1.28M Hold
9,027
0.23% 75
2015
Q3
$1.1M Buy
9,027
+242
+3% +$31.5K 0.28% 69
2015
Q2
$1.14M Hold
8,785
0.37% 49
2015
Q1
$1.18M Hold
8,785
0.37% 48
2014
Q4
$1.1M Buy
+8,785
New +$1.07M 0.32% 56

Other funds holding TMO

Ninety One North America's TMO Position: Q2 2026 in Review

Ninety One North America held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 7,390 shares worth $3.71M. The position accounts for 0.17% of the portfolio, ranked #81.

Ninety One North America first reported a position in TMO in Q4 2014 and has held it in 41 quarters since. The position peaked at $30.2M in Q4 2019. 1,133 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ninety One North America held 7,390 shares of Thermo Fisher Scientific worth $3.71M as of Q2 2026.
  • Ninety One North America left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.17% of Ninety One North America's portfolio in Q2 2026, its #81 holding.
  • Ninety One North America first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 41 quarters since.
  • Ninety One North America's Thermo Fisher Scientific position peaked at $30.2M in Q4 2019.
  • 1,133 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ninety One North America's 13F filing for Q2 2026, filed 16 Jul 2026.